Monoclonal Antibody-Based Targeted Therapy in Breast Cancer

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 2, 2005-03 ,pp. : 99-106

Bentham Science Publishers

Access to resources Recommend Favorite

Reactivity of monoclonal antibody FC-2.15 against drug resistant breast cancer cells. Additive cytotoxicity of adriamycin and taxol with FC-2.15

By Ballaré C.  

Breast Cancer Research and Treatment, Vol. 47, Iss. 2, 1998-01 ,pp. : 163-170

Springer Publishing Company

Access to resources Recommend Favorite

Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies

By Iannello Alexandre   Ahmad Ali  

Cancer and Metastasis Reviews, Vol. 24, Iss. 4, 2005-12 ,pp. : 487-499

Springer Publishing Company

Access to resources Recommend Favorite

CD44v6: a target for antibody-based cancer therapy

By Heider Karl-Heinz   Kuthan Hartmut   Stehle Gerd   Munzert Gerd  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 7, 2004-07 ,pp. : 567-579

Springer Publishing Company

Access to resources Recommend Favorite

Preclinical Therapy of Breast Cancer with a Radioiodinated Humanized Anti-EGP-1 Monoclonal Antibody: Advantage of a Residualizing Iodine Radiolabel

By Govindan Serengulam V.   Stein Rhona   Qu Zhengxing   Chen Susan   Andrews Philip   Ma Hong   Hansen Hans J.   Griffiths Gary L.   Horak Ivan D.   Goldenberg David M.  

Breast Cancer Research and Treatment, Vol. 84, Iss. 2, 2004-03 ,pp. : 173-182

Springer Publishing Company

Access to resources Recommend Favorite